Correlation Between Cytosorbents Crp and Vivos Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cytosorbents Crp and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytosorbents Crp and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytosorbents Crp and Vivos Therapeutics, you can compare the effects of market volatilities on Cytosorbents Crp and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytosorbents Crp with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytosorbents Crp and Vivos Therapeutics.
Diversification Opportunities for Cytosorbents Crp and Vivos Therapeutics
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cytosorbents and Vivos is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Cytosorbents Crp and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Cytosorbents Crp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytosorbents Crp are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Cytosorbents Crp i.e., Cytosorbents Crp and Vivos Therapeutics go up and down completely randomly.
Pair Corralation between Cytosorbents Crp and Vivos Therapeutics
Given the investment horizon of 90 days Cytosorbents Crp is expected to under-perform the Vivos Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cytosorbents Crp is 1.24 times less risky than Vivos Therapeutics. The stock trades about -0.03 of its potential returns per unit of risk. The Vivos Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 1,126 in Vivos Therapeutics on September 20, 2024 and sell it today you would lose (636.00) from holding Vivos Therapeutics or give up 56.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cytosorbents Crp vs. Vivos Therapeutics
Performance |
| Timeline |
| Cytosorbents Crp |
| Vivos Therapeutics |
Cytosorbents Crp and Vivos Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cytosorbents Crp and Vivos Therapeutics
The main advantage of trading using opposite Cytosorbents Crp and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytosorbents Crp position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.| Cytosorbents Crp vs. LivaNova PLC | Cytosorbents Crp vs. Electromed | Cytosorbents Crp vs. Orthopediatrics Corp | Cytosorbents Crp vs. SurModics |
| Vivos Therapeutics vs. Avita Medical | Vivos Therapeutics vs. Inogen Inc | Vivos Therapeutics vs. Apyx Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |